| Vasculitis and related conditions | Lifetime | 40 | ES 3 | 99.31 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 26 | ES 3 | 98.92 |
| Systemic Lupus Erythematosus Research | Lifetime | 353 | ES 11 | 98.85 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 307 | ES 9 | 98.72 |
| Urticaria and Related Conditions | Lifetime | 182 | ES 5 | 98.20 |
| Inflammasome and immune disorders | Lifetime | 244 | ES 4 | 97.52 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 267 | ES 7 | 98.19 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 277 | ES 6 | 97.72 |
| Spondyloarthritis Studies and Treatments | Lifetime | 197 | ES 12 | 97.90 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 209 | ES 6 | 96.84 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 599 | ES 12 | 95.83 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 919 | ES 34 | 93.70 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 167 | ES 12 | 90.90 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 410 | ES 4 | 89.27 |
| Autoimmune and Inflammatory Disorders | Lifetime | 917 | ES 42 | 88.62 |
| Vasculitis and related conditions | 2021-2025 | 47 | ES 4 | 98.04 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 167 | ES 6 | 97.29 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 207 | ES 6 | 96.23 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 89 | ES 4 | 97.12 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 190 | ES 5 | 95.45 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 111 | ES 6 | 94.31 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 56 | ES 5 | 93.61 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 489 | ES 15 | 93.43 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 168 | ES 6 | 92.34 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 259 | ES 6 | 90.85 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 349 | ES 20 | 92.24 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 405 | ES 18 | 89.75 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 415 | ES 16 | 85.39 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 943 | ES 33 | 75.15 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 205 | ES 3 | 73.00 |
| Cell Adhesion Molecules Research | 2021-2025 | 764 | ES 14 | 71.58 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 702 | ES 20 | 74.12 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 611 | ES 30 | 67.36 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 730 | ES 44 | 53.54 |
